Studies have shown that exosomes from cancer stem cells in HCC can upregulate Bax (BCL2 associated X, apoptosis regulator), p53 and Bcl2 (BCL2 apoptosis regulator), thereby reducing tumor growth, progression and metastasis [76]. The gene discussed is BAX; the disease is hepatocellular carcinoma.